BL-001 Designed to Replicate the Antiepileptic Effects of the Ketogenic Diet Topline Results including Safety and Tolerability Expected in Third Quarter of 2023 SAN DIEGO, April 25, 2023 /PRNewswire/ ...
SAN DIEGO, April 25, 2023 /PRNewswire/ -- Bloom Science, Inc., a clinical-stage, central nervous system (CNS) company focused on discovering and developing breakthrough therapeutics that target the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results